• Explore /
  • Poster
  • / Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naïve prostate cancer: Single institution experience.

Upfront docetaxel with androgen deprivation therapy in the elderly patient with metastatic hormone-naïve prostate cancer: Single institution experience.

Abstract Poster

Authors

null

Lindsay Jennifer Andrew Rayner

Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom

Lindsay Jennifer Andrew Rayner , Amarnath Challapalli , Eve Blackmore , Katherine Rea , Natasha Wells , Paul White , Serena Hilman , Susan Masson , Rebecca Huckett , Krishna Garadi , Hannah Kirk , Julian Kabala , Viktoria Oikonomopoulou , Amit Bahl

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer, Urothelial Carcinoma, and Penile, Urethral, and Testicular Cancers

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Prostate Cancer - Advanced Disease

Citation

J Clin Oncol 36, 2018 (suppl 6S; abstr 328)

DOI

10.1200/JCO.2018.36.6_suppl.328

Abstract #

328

Poster Bd #

C19

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

<span>Use of prostate cancer subtyping by gene expression to predict response to radiation and chemohormonal therapies.</span>

Use of prostate cancer subtyping by gene expression to predict response to radiation and chemohormonal therapies.

First Author: Adam B Weiner

First Author: Giulia Baciarello

First Author: Carlo Buonerba

First Author: Fernando C. Maluf